dimyristoyl lecithin

dimyristoyl lecithin (IMAGENT) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

IMAGENT is a marketed brand name for dimyristoyl lecithin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

dimyristoyl lecithin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.